| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Business Officer +1 more
3 companies
Henderson Michael Thomas is a Chief Executive Officer at APGE, with reported holdings spanning 3 companies. Recent filings cover 1 purchase and 72 sales. Those positions are worth an estimated $155.1M at current prices.
Our model assigns Henderson Michael Thomas a middling insider score of 57/100, based on 14 past trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -20.8%.
Henderson Michael Thomas's largest disclosed position is in APGE as Chief Executive Officer, worth about $124.2M. The recent filings there lean toward selling, a net 425,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $48.85 | $732,692.88 | -0.6% | -41.5% | +57.4% | |
| Dec 4, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $46.58 | $698,653.68 | -0.6% | -41.6% | +45.1% | |
| Nov 6, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $59.22 | $888,320.00 | -0.6% | -31.2% | -6.5% | |
| Oct 2, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 40,000 | $56.23 | $2,249,307.04 | -1.4% | -19.4% | -29.6% | |
| Sep 4, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 40,000 | $47.62 | $1,904,841.05 | -1.4% | -1.5% | -20.9% | |
| Aug 7, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 40,000 | $40.62 | $1,624,764.04 | -0.9% | +42.6% | -11.9% | |
| Jul 5, 2024 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $37.26 | $558,900.00 | -1.0% | +49.5% | +3.2% | |
| Dec 1, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $51.52 | $515,204.08 | -1.8% | - | - | |
| Nov 16, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $45.00 | $450,000.00 | -3.6% | - | - | |
| Nov 2, 2020 | BBIO Bridgebio Pharma, Inc. | Chief Business Officer | Sale+OE | 10,000 | $38.36 | $383,557.65 | -1.8% | - | - |